Table 1.
Tumors Used for DNA Microarray Analysis
| MIT*† | MIT-PD*† | MIT-MET*† | UM* | UVA‡ | |
|---|---|---|---|---|---|
| Breast | 11 | 5 | 1 | 0 | 26 |
| Prostate | 10 | 0 | 4 | 0 | 26 |
| Lung | 11 | 8 | 1 | 91 | 14 |
| Colon | 11 | 3 | 1 | 60 | 23 |
| Lymphoma | 22 | 0 | 0 | 0 | 0 |
| Melanoma | 10 | 0 | 0 | 0 | 0 |
| Bladder | 11 | 0 | 0 | 0 | 8 |
| Uterus | 10 | 1 | 0 | 6 | 0 |
| Leukemia | 30 | 0 | 0 | 0 | 0 |
| Kidney | 11 | 0 | 0 | 0 | 11 |
| Pancreas | 11 | 0 | 0 | 10 | 60 |
| Ovary | 11 | 3 | 1 | 113 | 27 |
| Mesothelioma | 11 | 0 | 0 | 0 | 0 |
| CNS | 20 | 0 | 0 | 73 | 0 |
| Total | 190 | 20 | 8 | 353 | 141 |
*Denotes data from Affymetrix HuGeneFL microarrays.
†Denotes data from Affymetrix Hu35KSubA microarrays.
‡Denotes data from Affymetrix HG-U95Av2 microarrays.